🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: indacaterol maleate

Found 35 matching trials

Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of Indacaterol/Mometasone Delivered Via the TWISTHALER® Device in Adult Patients With Persistent Asthma

PHASE2

This study is designed to provide data about the 24 hours FEV1 profile, saf...

Status

Completed

Location

Novartis Investigator Site

Start Date

2007-11

Trial ID

NCT00557440

Treatments Being Tested

fluticasone propionate/salmeterol indacaterol maleate / mometasone furoate placebo to indacaterol/mometasone placebo to fluticasone propionate/salmeterol

A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation

PHASE3

This study will assess the efficacy, safety and tolerability of indacaterol...

Status

Completed

Location

Novartis Investigative Site

Start Date

2012-12

Trial ID

NCT01712516

Treatments Being Tested

QVA149 QAB149 NVA237 Placebo

Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.

PHASE2

This study is a randomized, double-blind, placebo-controlled, three-period ...

Status

Completed

Location

Novartis Investigative Site

Start Date

2017-09-05

Trial ID

NCT03257995

Treatments Being Tested

Indacaterol maleate Indacaterol acetate Placebo

Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Maleate Via Concept1 or Simoon Devices

PHASE2

This study assessed the efficacy, safety, tolerability, and pharmacokinetic...

Status

Completed

Location

Novartis Investigative Site

Start Date

2009-10

Trial ID

NCT01012739

Treatments Being Tested

Indacaterol 150 μg via the Concept1 dry-powder inhaler Indacaterol 60 μg via the Simoon dry-powder inhaler Indacaterol 120 μg via the Simoon dry-powder inhaler Placebo to indacaterol via the Concept1 dry-powder inhaler

Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen

PHASE4

The main goal of this study is to evaluate the efficacy and safety of glyco...

Status

Completed

Location

Novartis Investigative Site

Start Date

2014-02-14

Trial ID

NCT01985334

Treatments Being Tested

Glycopyrronium SABA LABA Indacaterol maleate and glycopyrronium bromide LAMA SAMA ICS

An Exploratory Study, to Assess the Effect of Repeat-dose Inhaled Indacaterol Maleate (300 μg) on Dynamic and Static Lung Hyperinflation, Subjective Breathlessness and Health Status in Patients With Chronic Obstructive Pulmonary Disease(COPD)

PHASE2

This study evaluated the effect of QAB149 on dynamic and static hyperinflat...

Status

Completed

Location

Novartis Investigator Site

Start Date

2008-02

Trial ID

NCT00636961

Treatments Being Tested

Indacaterol 300μg Placebo

A Study to Assess the Efficacy and Safety of HRG2005 Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

PHASE2

This is a randomized, double blind, double dummy, active-controlled, parall...

Status

Terminated

Location

Peking University Third Hospital

Start Date

2024-01-15

Trial ID

NCT06035393

Treatments Being Tested

HRG2005 inhalation Placebo to match HRG2005 inhalation Placebo to match Indacaterol Maleate and Glycopyrronium Bromide Powder for inhalation Indacaterol Maleate and Glycopyrronium Bromide Powder for inhalation

Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma

PHASE2

The study is designed to obtain safety and efficacy data on three dose leve...

Status

Completed

Location

Colorado Allergy and Asthma Centres, P.C.

Start Date

2006-11

Trial ID

NCT00403637

Treatments Being Tested

indacaterol maleate

Safety and Tolerability of Indacaterol Maleate/Mometasone Furoate Delivered Via the Twisthaler® Device After 14 Days Treatment in Patients With Mild to Moderate Asthma

PHASE2

This study will investigate the safety and tolerability of indacaterol male...

Status

Completed

Location

Novartis Investigator Site

Start Date

2008-01

Trial ID

NCT00605306

Treatments Being Tested

indacaterol maleate / mometasone furoate placebo to indacaterol maleate/mometasone furoate

Closing Volume Interpretation and Bronchodilators Effect

PHASE4

* The gold standard measures to evaluate small airways (SAW) "in vivo" is n...

Status

Completed

Location

Pneumologia Riabilitativa-Fondazione Maugeri-Istituto Scientifico di Milano- IRCCS

Start Date

2011-08

Trial ID

NCT01437748

Treatments Being Tested

Indacaterol maleate Tiotropium bromide

Previous Next